4.8 Article

Gadd45β promotes hepatocyte survival during liver regeneration in mice by modulating JNK signaling

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 118, Issue 5, Pages 1911-1923

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI33913

Keywords

-

Funding

  1. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom
  2. Cancer Research UK [A8839] Funding Source: Medline
  3. NCI NIH HHS [CA84040, R01 CA084040, R01 CA098583, CA98583] Funding Source: Medline
  4. NIDDK NIH HHS [DK067187, K08 DK067187] Funding Source: Medline

Ask authors/readers for more resources

In the liver, the JNK cascade is induced downstream of TNF receptors (TNFRs) in response to inflammatory, microbial, and toxic challenges. Sustained activation of JNK triggers programmed cell death (PCD), and hepatocyte survival during these challenges requires induction of the NF-kappa B pathway, which antagonizes this activation by upregulating target genes. Thus, modulation of JNK activity is crucial to the liver response to TNFR-mediated challenge. The basis for this modulation, however, is unknown. Here, we investigated the role of the NF-kappa B target Gadd45b in the regulation of hepatocyte fate during liver regeneration after partial hepatectomy. We generated Gadd45b(-/-) mice and found that they exhibited decreased hepatocyte proliferation and increased PCD during liver regeneration. Notably, JNK activity was markedly increased and sustained in fivers of Gadd45b(-/-) mice compared with control animals after partial hepatectomy. Furthermore, imposition of a Jnk2-null mutation, attenuating JNK activity, completely rescued the regenerative response in Gadd45b(-/-) mice. Interestingly, Gadd45 beta ablation did not affect hepatotoxic JNK signaling after a TNFR-mediated immune challenge, suggesting specificity in the inducible hepatic program for JNK restraint activated during distinct TNFR-mediated challenges. These data provide a basis for JNK suppression during liver regeneration and identify Gadd45 beta as a potential therapeutic target in liver diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available